PLGA Microbubble Composition for Stable Controlled Cavitation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing synthetic microbubbles for therapeutic applications are not optimized for cavitation enhancement, have a limited half-life, and can cause adverse effects such as bleeding and hemorrhage in healthy tissues, requiring repeated injections and varying cavitation activities for different treatments.

Innovation Solution

Development of stable and durable polymeric microbubbles with a PLGA shell, synthesized via a modified double emulsion solvent evaporation method, allowing control over size, structure, and cavitation activity, suitable for diverse therapeutic applications.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of moving object

If synthetic microbubbles are used for therapeutic applications, then cavitation enhancement is achieved, but half-life is limited and repeated injections are required

Engineering Contradiction:
Improvehalf-lifeVSAvoidcavitation enhancement
Core Design Contradiction:
Duration of action of moving objectVSReliability

Solution Approach 1:

The patent employs composite microbubble structure consisting of biodegradable PLGA polymer shell encapsulating inert gas core. The PLGA shell provides structural integrity and prolonged stability in bloodstream, while the gas core enables acoustic cavitation. This composite design resolves the contradiction by combining materials with complementary properties - the polymer shell extends half-life while the gas core maintains cavitation capability

Inventive Principle:
Principle #40Composite materials

2Object-affected harmful factors

If microbubbles are used for cavitation therapy, then tissue permeability is enhanced, but tissue damage such as bleeding and hemorrhage occurs

Engineering Contradiction:
Improvetissue damageVSAvoidadverse effects
Core Design Contradiction:
Object-affected harmful factorsVSObject-generated harmful factors

Solution Approach 1:

The patent applies partial cavitation action by controlling acoustic parameters and microbubble concentration to achieve sufficient tissue permeability enhancement without excessive cavitation intensity. The PLGA shell composition and gas core pressure are optimized to produce controlled, partial collapse that opens blood-brain barrier or tumor vasculature without causing severe tissue damage such as hemorrhage, thereby resolving the contradiction between therapeutic efficacy and safety

Inventive Principle:
Principle #16Partial or excessive action

3Adaptability or versatility

If different cavitation activities are used for different treatments, then treatment effectiveness is improved, but device complexity and injection protocols become more complex

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidinjection protocols
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent creates dynamically adjustable microbubble systems where cavitation activity can be modulated by controlling acoustic parameters (frequency, intensity, pulse duration) and microbubble concentration rather than requiring different formulations. The PLGA shell and gas core are designed to respond dynamically to varying acoustic fields, enabling the same microbubble preparation to be used for different treatments with adjusted delivery parameters, thus reducing device and protocol complexity while preserving adaptability

Inventive Principle:
Principle #15Dynamics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The PLGA microbubbles provide controlled acoustic cavitation with enhanced stability and safety, reducing the need for repeated injections and minimizing tissue damage, suitable for treatments like BBB opening and tumor ablation.

Implementation Method 1

Acoustic cavitation is the formation of gas bubbles, and activity (growth, oscillations or collapse) of existing gas bubbles in a medium exposed to ultrasound. In this process, mechanical effects such as microstreaming, microjets, and shock waves can be produced.

Methodology Applied
Scientific EffectAcoustic cavitation: Acoustic Cavitation

Implementation Method 2

synthetic, biocompatible microbubbles (MBs) made of gas encapsulated inside a solid shell... exposed to ultrasound

Methodology Applied
Scientific EffectUltrasound: Ultrasound

Data Source

PatentUS12527869B2Stable microspheres, method off abrication and use thereof
Publication Date: 2026.01.20 BG NEGEV TECHNOLOGIES & APPLICATIONS LTD
  • US12527869B2 patent drawing
  • US12527869B2 patent drawing
  • US12527869B2 patent drawing

AI summary

Stable and durable polymeric microbubbles of a 1-10 μm size range are disclosed. The microbubbles are synthesized from the co-polymer poly lactic-co-glycolic acid (PLGA), which provides a plurality of PLGA microbubbles presenting diverse cavitation activities. The PLGA microbubbles are particularly suitable for cavitation enhancement purposes and are applicable in various clinical procedures such as ablation or enhancement of uptake of chemical or biological therapy in cells and tissue.